Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer
DALLAS, TEXAS AND OSS, THE NETHERLANDS – 4 November 2026 – Trained Therapeutix Discovery (“TTxD”), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, announces the appointment of Andrew Glass as Chief Executive Officer with immediate effect. Mr. Glass has more than…




